Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Morphosys AG (OTC Pink - Current Information:MPSYY)

36.69
Delayed Data
As of Jul 27
 0.00 / 0.00%
Today’s Change
19.84
Today|||52-Week Range
41.63
+43.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.1B

Company Description

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics and research applications. It operates through the following segments: Partnered Discovery and Proprietary Development. The Partnered Discovery segment involves technologies for the generation of human antibody therapeutics, which are exploited through partnerships with pharmaceutical and biotechnology companies. The Proprietary Development segment includes activities relating to proprietary development of therapeutic antibodies and peptides. It also engages in the development of therapeutic candidates for cancer and inflammation. The company was founded by Andreas Plückthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Contact Information

MorphoSys AG
Semmelweisstrasse 7
Planegg Bayern (bavaria) 82152
P:(498) 989-9270
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Simon E. MoroneyChief Executive Officer
Jens HolsteinChief Financial Officer
Markus EnzelbergerChief Scientific Officer
Axel MeschederChief Medical Officer
Steffen HeegerHead-Clinical Development